India primed for biostatic outsourcing boom; CMO Aenove sold for $782M;

> India's market for the outsourcing of biostatic research is set to boom thanks to competitive pricing and burgeoning infrastructure, according to Beroe. News

> Bridgeport sold Munich-based CMO Aenove Group to BC Partners for a reported $782 million. The company operates in 5 countries across Europe and North America and has about 1,600 employees. Article

> The EMA is seeking CRO and sponsor input on a proposal to publicize more raw clinical trial data. The agency is looking to support independent research and public health without breaching patient confidentiality. Item

> India's custom research and manufacturing industry is also predicted to explode, with analysts forecasting 41.4% growth--more than three times the rate in the rest of the world. More

> German CRO Verum.de is targeting the U.S. market with the opening of a new facility in Carlsbad, CA. Release

> Almac says demand for its biologics work is on the rise, and the company is doubling its refrigeration capacity to accommodate the growth. Report

> Cato Research has signed a deal with Israel's Pluristem Therapeutics to conduct Phase II trials for a intermittent claudication treatment. News

Suggested Articles

Dubbed “Project Nightingale,” the efforts were announced amid concerns and federal inquiries into the data’s safekeeping and patient consent for use.

Independent site management organization Panthera Biopartners has kick-started its first clinical trial in the U.K.

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.